Clinical Trial Update: Exosome-based OCS Scores for Predicting Ovarian Cancer Recurrence

View source ↗

Summary

A clinical trial update describing exosome-based OCS scores aimed at predicting ovarian cancer recurrence; the study is currently NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Lei Li | Conditions: Ovarian Cancer | Status: NOT_YET_RECRUITING